ArticleCureus2024
Association of White Matter Hyperintensities With Serum Lipid Profile and Hematologic Parameters in Migraine Patients.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Migraine is one of the most common neurological diseases. Comorbidities, especially stroke, may be observed. White matter hyperintensities are common in migraine patients. Although many factors have been associated with white matter hyperintensities, such as age, gender, migraine type, frequency, and presence of aura, the etiology of white matter hyperintensities remains unclear. We aimed to study the relationship between the development of white matter hyperintensities and serum lipid profiles and hematologic parameters in migraine patients. Methods Demographic data, comorbidities, migraine types, presence of aura, and frequency of attacks were reviewed. Cranial MRI scans, hematologic profiles, and lipid profiles were analyzed. Results The study included 51 patients with white matter hyperintensity on cranial MRI and 76 migraine patients with normal cranial MRI. High-density lipoprotein cholesterol (HDL-c) was statistically significantly higher in the patients with white matter hyperintensity in the cranial MRI (WMH+) group. A statistically significant cut-off value was found for the PLR parameter in differentiating white matter hyperintensity on cranial MRI in migraine patients. Conclusion In our study, we examined the factors contributing to the development of white matter hyperintensity in migraine patients and observed the correlation between disease duration and white matter hyperintensity. While no correlation was observed between low-density lipoprotein cholesterol (LDL-c) and white matter hyperintensity, HDL-c was dramatically elevated in patients with white matter hyperintensity. Furthermore, our study shows that PLR is a useful, easily accessible, and practical parameter for detecting the development of white matter hyperintensity in migraine patients. Larger-scale randomized studies are needed for a clearer interpretation of these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.